Insider Transactions in Q3 2022 at Paratek Pharmaceuticals, Inc. (PRTK)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 09
2022
|
Evan Loh CEO |
SELL
Open market or private sale
|
Direct |
44,519
-3.42%
|
$89,038
$2.66 P/Share
|
|
Aug 09
2022
|
William M. Haskel CLO, General Counsel & Sec. |
SELL
Open market or private sale
|
Direct |
22,453
-4.93%
|
$44,906
$2.66 P/Share
|
|
Aug 09
2022
|
Randall B. Brenner Chief Development & Regulatory |
SELL
Open market or private sale
|
Direct |
19,608
-5.32%
|
$39,216
$2.66 P/Share
|
|
Aug 09
2022
|
Michael Bigham Exec. Chairman of the Board |
SELL
Open market or private sale
|
Direct |
28,637
-2.32%
|
$57,274
$2.66 P/Share
|
|
Aug 08
2022
|
Adam Woodrow President & Chief Commercial |
BUY
Grant, award, or other acquisition
|
Direct |
71,591
+10.13%
|
-
|
|
Aug 08
2022
|
Evan Loh CEO |
BUY
Grant, award, or other acquisition
|
Direct |
152,727
+10.5%
|
-
|
|
Aug 08
2022
|
William M. Haskel CLO, General Counsel & Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
47,727
+9.49%
|
-
|
|
Aug 08
2022
|
Randall B. Brenner Chief Development & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
47,727
+11.46%
|
-
|
|
Aug 08
2022
|
Michael Bigham Exec. Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
143,182
+10.38%
|
-
|